Clinverse Inc., a Charlotte-based technology company, has received $2.2 million in financing.
The funds will be used to develop ClinPay, an electronic-payment network used for drug trials in the pharmaceutical industry.
The money comes from an investment syndicate that comprises current investors and Vital Financial, an investment bank based in Bethesda, Md.
“We are pleased to have rounded out our investment with significant funding from Vital Financial,” says Steve Ayala, Clinverse president. “Not only is Vital adding to our capital base, but they also are contributing their team’s experience in growing successful software companies.”
Clinverse focuses on the financial management of clinical trials and associated payments. The company was founded in July 2008 and has eight employees. Clinverse is seeking to hire a senior vice president of sales and marketing and four programmers.
Source: Charlotte Business Journal
